Atara Biotherapeutics announces pricing of $150.0 million public offering
Atara Biotherapeutics announced pricing of an underwritten public offering of 6,871,727 shares of its common stock at a price to the public of $15.28 per share. In addition, and in lieu of common stock, Atara is offering to certain investors pre-funded warrants to purchase 2,945,026 shares. July 19, 2019